Brind.

Paul Manning purchased shares of Candel Therapeutics, amid discussion of potential benefits from Trump's policies for US stocks.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Donald Trump Candel Therapeutics Paul Manning

Keep exploring

The entities involved

Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Trump ended the ceasefire agreement with Iran following recent attacks by Iranian forces.Mon 18:02
- The Trump administration utilized the Department of Health & Human Services for an AI tool.Mon 18:02
Candel Therapeutics
company in Auburndale, United States

Nothing else this week.
Paul Manning
researcher (ORCID 0000-0002-9697-9203)

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet